文献速递肥胖与代谢综合征

激活素在脂肪细胞中的作用

Activin Actions in Adipocytes.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

肥胖是脂肪过度堆积的全球健康问题,现有减重药物存在局限,因此需明确调控脂肪量的机制以开发新疗法。本文综述TGFβ家族配体激活素在脂肪细胞增殖、分化和功能中的作用,重点讨论肝因子激活素E在脂解和饮食诱导肥胖中的作用。

要点

  • 激活素属于TGFβ家族配体,参与调控脂肪细胞的增殖、分化与功能。
  • 肝因子激活素E在脂解和饮食诱导肥胖中发挥作用。
  • 现有减重药物存在费用高、可及性不均、需持续使用及副作用等局限。

核心结论

  • 激活素在脂肪细胞增殖、分化和功能中发挥作用,肝因子激活素E参与脂解和饮食诱导肥胖的调控。

研究设计与样本

  • 综述,聚焦TGFβ家族配体激活素在脂肪细胞增殖、分化和功能中的作用,重点讨论肝因子激活素E在脂解和饮食诱导肥胖中的作用。

主要发现

  • 近年来对TGFβ家族配体激活素在脂肪细胞增殖、分化和功能中的作用日益受到重视。
  • 肝因子激活素E在脂解和饮食诱导肥胖中发挥作用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Obesity is a growing global health problem characterized by excess fat accumulation. Though causes of obesity are multifactorial, glucagon-like peptide 1 receptor agonists have emerged as effective weight loss drugs. Nevertheless, these agents are expensive, not uniformly available, and must be used continuously. Moreover, side effects and low efficacy limit the use of these and related molecules in some individuals. Therefore, there is continued interest in characterizing mechanisms regulating adiposity to aid in the development of novel treatments. In recent years, there has been a growing appreciation for ligands of the TGFβ family, the activins, in adipocyte proliferation, differentiation, and function. Here, we review recent progress in understanding the role of these molecules, with a particular focus on the hepatokine, activin E, in lipolysis and diet-induced obesity.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ongaro L, Bernard DJ. Activin Actions in Adipocytes. J Clin Endocrinol Metab. 2025. PMID: 40208114. doi:10.1210/clinem/dgaf233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。